CYP21 Genotype, Adult Height, and Pubertal Development in 55 Patients Treated for 21-Hydroxylase Deficiency
The DOI matches its Crossref record; 33 of the 37 references it cites were found in a registry or an index.
Abstract
In a retrospective study we evaluated long-term growth, pubertal developmental patterns to final height (FH), and medication in 55 patients (35 females) affected by 21-hydroxylase deficiency. The patients were classified into 3 groups according to predicted mutation severity: group A (11 women and 9 men), homozygous or compound heterozygous for null or In2 splice mutations [residual enzymatic activity (RA), <1%]; group B (11 women and 4 men), homozygous for I172N or R341P or R426H mutations (RA, approximately 2-3%) or compound heterozygous with any of the group A or B mutations; and group C (13 women and 7 men), homozygous for P30L or V281L or P453S mutations (RA, >30%) or compound heterozygous with any of the group A, B, or C mutations. Three patients showed unclassifiable genotypes. FH was similar in the female groups, whereas male patients in group B were shorter than males in groups A and C. Fifty-five percent of patients in group A, 33% in group B, and 40% in group C reached an FH within 0.5 SD of target height. Four of the 7 patients diagnosed via neonatal screening achieved an FH equal to or above the target height. In the entire group, early diagnosis (<1 yr) improved height outcome. Early diagnosed CAH patients who received lower cortisol equivalent doses during the first year of life reached a better FH. Our results underline the importance of mineralocorticoid therapy, as CAH subjects in groups A and B who did not receive this treatment showed reduced FH. Early diagnosis, the use of more physiological cortisol equivalent dosages during the first year of life, and the extension of mineralocorticoid therapy to all classical patients are shown to improve the auxological outcome. Genotypic analysis helped to interpret the height results of our cases and prospectively may represent a useful tool for improving the therapeutic choice and the height outcome.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“A similar correlation of severity with genotype is seen when evaluating genital appearance in adult women (224).”
From Congenital Adrenal Hyperplasia—Current Insights in Pathophysiology, Diagnostics, and Management (2022) · cites this paper as [224]
In the citing paper
“There are limited data directly correlating psychosexual functioning with genotype (224,225),”
From Congenital Adrenal Hyperplasia—Current Insights in Pathophysiology, Diagnostics, and Management (2022) · cites this paper as [224]
In the citing paper
“When doses exceed 20 mg/m 2 per day in infants or 15 to 17 mg/m 2 per day in adolescents, there is a decrease in height standard deviation score (SDS), leading to a decreased adult height SDS (196)(197)(198)(199).”
From Congenital Adrenal Hyperplasia Due to Steroid 21-Hydroxylase Deficiency: An Endocrine Society* Clinical Practice Guideline (2018) · cites this paper as [196]
Citations
Cites
Variations in pattern of pubertal changes in girls
Marshall, W. A., & Tanner, J. M. (1969) · Archives of Disease in Childhood · doi:10.1136/adc.44.235.291 · Cited by 5,963
Variations in the pattern of pubertal changes in boys
Marshall, W. A., & Tanner, J. M. (1970) · Archives of Disease in Childhood · doi:10.1136/adc.45.239.13 · Cited by 5,147 · cited 3×
“Pubertal maturation was assessed by the Marshall and Tanner method (14, 15), whereas body mass index (BMI; kilograms per square meter) sd scores were calculated according to the reference standards of Roland-Cachera et al.”
BackgroundMethodTanner, J. M., Whitehouse, R. H., & Takaishi, M. (1966) · Archives of Disease in Childhood · doi:10.1136/adc.41.220.613 · Cited by 2,553
Tanner, J. M., Whitehouse, R. H., & Takaishi, M. (1966) · Archives of Disease in Childhood · doi:10.1136/adc.41.219.454 · Cited by 1,345
Bayley, N., & Pinneau, S. R. (1952) · The Journal of Pediatrics · doi:10.1016/s0022-3476(52)80205-7 · Cited by 1,196
Body Mass Index variations: centiles from birth to 87 years.
Rolland‐Cachera, M., Cole, T. J., Sempe, M., Tichet, J., Rossignol, C., & Charraud, A.-M. (1991) · PubMed · Cited by 1,127
Speiser, P. W., Dupont, J., Zhu, D., Serrat, J., Buegeleisen, M., Tusie-Luna, M. T., Lesser, M., New, M. I., & White, P. C. (1992) · Journal of Clinical Investigation · doi:10.1172/jci115897 · Cited by 572 · cited 2×
“Group A consisted of patients homozygous or compound heterozygous for null (deletion, large/small conversion, Del8bp, CluE6) or In2 splice (In2) mutations [residual enzymatic activity (RA), 1%; Table 1, cases 1–20) (7, 8).”
BackgroundItalian cross-sectional growth charts for height, weight and BMI (6–20 y)
Cacciari, E., Milani, S., Balsamo, A., Dammacco, F., De Luca, F., Chiarelli, F., Pasquino, A., Tonini, G., & Vanelli, M. (2002) · European Journal of Clinical Nutrition · doi:10.1038/sj.ejcn.1601314 · Cited by 387
Self-citationWedell, A. (1994) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.78.5.1145 · Cited by 370
Long Term Outcome in Adult Males with Classic Congenital Adrenal Hyperplasia1
Cabrera, M. S., Vogiatzi, M. G., & New, M. I. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.7.7668 · Cited by 204
Research works printed but not linked: 4
- Aicardi, 1986, Affidabilitá dei più comuni metodi di previsione della statura adulta in un campione di adolescenti italiani., Acta Med Auxol, 18, 55
- Ehrlich, 1989, Electrolyte metabolism, 1594
- Styne, 1977, Growth patterns in congenital adrenal hyperplasia: correlation of glucocorticoid therapy with stature, In: Lee PA, Plotnick LP, Kowarski AA, Migeon CJ, eds. Congenital adrenal hyperplasia. Baltimore: University Park Press;, 247
- New, 1989, Final height in classical and non classical 21-hydroxylase deficiency adrenal hyperplasis, In: Bierich JR, Cacciari E, Raiti S, eds. Growth abnormalities. New York: Raven Press;, 51
Cited by
Speiser, P. W., Azziz, R., Baskin, L. S., Ghizzoni, L., Hensle, T. W., Merke, D. P., Meyer-Bahlburg, H. F. L., Miller, W. L., Montori, V. M., Oberfield, S. E., et al. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-2631 · Cited by 1,468
Speiser, P. W., Arlt, W., Auchus, R. J., Baskin, L. S., Conway, G. S., Merke, D. P., Meyer-Bahlburg, H. F. L., Miller, W. L., Murad, M. H., Oberfield, S. E., et al. (2018) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2018-01865 · Cited by 1,234
Congenital Adrenal Hyperplasia—Current Insights in Pathophysiology, Diagnostics, and Management
Claahsen - van der Grinten, H. L., Speiser, P. W., Ahmed, S. F., Arlt, W., Auchus, R. J., Falhammar, H., Flück, C. E., Guasti, L., Huebner, A., Kortmann, B. B. M., et al. (2022) · Endocrine Reviews · doi:10.1210/endrev/bnab016 · Cited by 556
Congenital adrenal hyperplasia due to 21-hydroxylase deficiency
Merke, D. P., & Auchus, R. J. (2020) · New England Journal of Medicine · doi:10.1056/nejmra1909786 · Cited by 341
Nonclassical 21-Hydroxylase Deficiency
New, M. I. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-1645 · Cited by 315
PW, S., W, A., RJ, A., LS, B., GS, C., DP, M., HFL, M.-B., WL, M., MH, M., SE, O., et al. (2019) · Yearbook of Paediatric Endocrinology · doi:10.1530/ey.16.8.5 · Cited by 300
Congenital adrenal hyperplasia
Auer, M. K., Nordenström, A., Lajic, S., & Reisch, N. (2023) · The Lancet · doi:10.1016/s0140-6736(22)01330-7 · Cited by 215
Forest, M. G. (2004) · Human Reproduction Update · doi:10.1093/humupd/dmh047 · Cited by 200
Adult Height in Patients with Congenital Adrenal Hyperplasia: A Systematic Review and Metaanalysis
Muthusamy, K., Elamin, M. B., Smushkin, G., Murad, M. H., Lampropulos, J. F., Elamin, K. B., Abu Elnour, N. O., Gallegos-Orozco, J. F., Fatourechi, M. M., Agrwal, N., et al. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-2616 · Cited by 182
“One author also provided data on two additional patients included in the cohort since the publication of the study (17).”
BackgroundAdrenal Steroidogenesis and Congenital Adrenal Hyperplasia
Turcu, A. F., & Auchus, R. J. (2015) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2015.02.002 · Cited by 177
“coid replacement and restoration of euvolemia decrease vasopressin and ACTH secretion, which often lowers the dose of glucocorticoid required to achieve adequate control of androgen production.(50,103) The dose of fludrocortisone is titrated to achieve”
BackgroundMethodBonfig, W., Bechtold, S., Schmidt, H., Knorr, D., & Schwarz, H. P. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-2109 · Cited by 167
Falhammar, H., Filipsson, H., Holmdahl, G., Janson, P.-O., Nordenskjöld, A., Hagenfeldt, K., & Thorén, M. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-1350 · Cited by 167
Nordenström, A., & Falhammar, H. (2019) · European Journal of Endocrinology · doi:10.1530/eje-18-0712 · Cited by 158
Clinical perspectives in congenital adrenal hyperplasia due to 11β-hydroxylase deficiency
Bulsari, K., & Falhammar, H. (2016) · Endocrine · doi:10.1007/s12020-016-1189-x · Cited by 149
Bonfig, W., Dalla Pozza, S. B., Schmidt, H., Pagel, P., Knorr, D., & Schwarz, H. P. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-0942 · Cited by 136
Lin-Su, K., Vogiatzi, M. G., Marshall, I., Harbison, M. D., Macapagal, M. C., Betensky, B., Tansil, S., & New, M. I. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-2128 · Cited by 111
Baumgartner-Parzer, S., Witsch-Baumgartner, M., & Hoeppner, W. (2020) · European Journal of Human Genetics · doi:10.1038/s41431-020-0653-5 · Cited by 110
Riepe, F. G., & Sippell, W. G. (2007) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-007-9053-1 · Cited by 108
Clinical outcomes in the management of congenital adrenal hyperplasia
Falhammar, H., & Thorén, M. (2012) · Endocrine · doi:10.1007/s12020-011-9591-x · Cited by 106
“final height have also been reported [57].”
How Many Deaths Can Be Prevented by Newborn Screening for Congenital Adrenal Hyperplasia?
Grosse, S. D., & Van Vliet, G. (2007) · Hormone Research in Paediatrics · doi:10.1159/000098400 · Cited by 102
“Although hormone replacement therapy and early diagnosis have been linked to increased adult height, this has not yet been established as a benefit of earlier detection [”
BackgroundChakhtoura, Z., Bachelot, A., Samara-Boustani, D., Ruiz, J.-C., Donadille, B., Dulon, J., Christin-Maître, S., Bouvattier, C., Raux-Demay, M.-C., Bouchard, P., et al. (2008) · European Journal of Endocrinology · doi:10.1530/eje-07-0887 · Cited by 90
“We noted low final height compared to target height, consistent with former publications (25-28), while onset-pubertal height was normal.”
ResultFinal Adult Height in Children with Congenital Adrenal Hyperplasia Treated with Growth Hormone
Lin-Su, K., Harbison, M. D., Lekarev, O., Vogiatzi, M. G., & New, M. I. (2011) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2010-2699 · Cited by 75
Impact of Molecular Genetics on Congenital Adrenal Hyperplasia Management
Balsamo, A., Baldazzi, L., Menabò, S., & Cicognani, A. (2010) · Sexual Development · doi:10.1159/000315959 · Cited by 54
Self-citationCongenital adrenal hyperplasia – pharmacologic interventions from the prenatal phase to adulthood
Claahsen-van der Grinten, H. L., Stikkelbroeck, N. M. M. L., Otten, B. J., & Hermus, A. R. M. M. (2011) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2011.05.004 · Cited by 53
Growth and development in children with classic congenital adrenal hyperplasia
Bonfig, W. (2016) · Current Opinion in Endocrinology Diabetes and Obesity · doi:10.1097/med.0000000000000308 · Cited by 52
Long-Term Outcomes of Congenital Adrenal Hyperplasia
Nordenström, A., Lajić, S., & Falhammar, H. (2022) · Endocrinology and Metabolism · doi:10.3803/enm.2022.1528 · Cited by 50
Rocha, R. O., Billerbeck, A. E. C., Pinto, E. M., Melo, K. F. S., Lin, C. J., Longui, C. A., Mendonca, B. B., & Bachega, T. A. S. S. (2008) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2007.03023.x · Cited by 43
Puberty and Fertility in Congenital Adrenal Hyperplasia
Otten, B. J., Stikkelbroeck, M. M. L., Claahsen-van der Grinten, H. L., & Hermus, A. R. M. M. (2005) · Endocrine Development · doi:10.1159/000084093 · Cited by 43
Guidelines for diagnosis and treatment of 21-hydroxylase deficiency (2014 revision)
Ishii, T., Anzo, M., Adachi, M., Onigata, K., Kusuda, S., Nagasaki, K., Harada, S., Horikawa, R., Minagawa, M., Minamitani, K., et al. (2015) · Clinical Pediatric Endocrinology · doi:10.1297/cpe.24.77 · Cited by 44
Clinical guidelines for the diagnosis and treatment of 21-hydroxylase deficiency (2021 revision)
Ishii, T., Kashimada, K., Amano, N., Takasawa, K., Nakamura‐Utsunomiya, A., Yatsuga, S., Mukai, T., Ida, S., Isobe, M., Fukushi, M., et al. (2022) · Clinical Pediatric Endocrinology · doi:10.1297/cpe.2022-0009 · Cited by 37
Characterization of novel missense mutations in CYP21 causing congenital adrenal hyperplasia
Robins, T., Bellanné‐Chantelot, C., Barbaro, M., Cabrol, S., Wedell, A., & Lajić, S. (2006) · Journal of Molecular Medicine · doi:10.1007/s00109-006-0121-x · Cited by 36
Self-citationHoepffner, W., Kaufhold, A., Willgerodt, H., & Keller, E. (2008) · Hormone Research in Paediatrics · doi:10.1159/000129677 · Cited by 34
Growth and Reproductive Outcomes in Congenital Adrenal Hyperplasia
Nebesio, T. D., & Eugster, E. A. (2010) · International Journal of Pediatric Endocrinology · doi:10.1155/2010/298937 · Cited by 34
Adult height of subjects with nonclassical 21-hydroxylase deficiency
Eyal, O., Tenenbaum‐Rakover, Y., Shalitin, S., Israel, S., & Weintrob, N. (2013) · Acta Paediatrica · doi:10.1111/apa.12147 · Cited by 33
“Similar to previous reports (5,16), there were more females than males in our study group and significantly more females in the later diagnosed group compared to the younger diagnosed group.”
BackgroundResultGrowth in Patients with Classic Congenital Adrenal Hyperplasia due to 21-Hydroxylase Deficiency
Dörr, H. G. (2007) · Hormone Research in Paediatrics · doi:10.1159/000110587 · Cited by 31
Bomberg, E. M., Addo, O. Y., Kyllo, J. H., Gonzalez‐Bolanos, M. T., Ltief, A. M., Pittock, S. T., Himes, J. H., Miller, B. S., & Sarafoglou, K. (2014) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2014.11.027 · Cited by 30
Congenital Adrenal Hyperplasia: Issues in Diagnosis and Treatment in Children
Sharma, R., & Seth, A. (2013) · The Indian Journal of Pediatrics · doi:10.1007/s12098-013-1280-8 · Cited by 31
Völkl, T. M. K., Öhl, L., Rauh, M., Schöfl, C., & Dörr, H. G. (2011) · Hormone Research in Paediatrics · doi:10.1159/000333696 · Cited by 29
Nimkarn, S., New, M. I., & Lin-Su, K. (2007) · Journal of Pediatric Endocrinology and Metabolism · doi:10.1515/jpem.2007.20.8.883 · Cited by 29
Kareva, M., & Чугунов, І. (2014) · Problems of Endocrinology · doi:10.14341/probl201460242-50 · Cited by 25
Kocova, M., Anastasovska, V., & Falhammar, H. (2020) · Endocrine · doi:10.1007/s12020-020-02323-3 · Cited by 24
Growth Trajectory and Adult Height in Children with Nonclassical Congenital Adrenal Hyperplasia
Wasniewska, M. G., Morabito, L. A., Baronio, F., Einaudi, S., Salerno, M., Bizzarri, C., Russo, G., Chiarito, M., Grandone, A., Guazzarotti, L., et al. (2020) · Hormone Research in Paediatrics · doi:10.1159/000509548 · Cited by 22
Self-citationDuration of Suppression of Adrenal Steroids after Glucocorticoid Administration
Fuqua, J. S., Rotenstein, D., & Lee, P. A. (2010) · International Journal of Pediatric Endocrinology · doi:10.1155/2010/712549 · Cited by 22
Bachelot, A., Chakhtoura, Z., Samara-Boustani, D., Dulon, J., Touraine, P., & Polak, M. (2010) · International Journal of Pediatric Endocrinology · doi:10.1155/2010/326275 · Cited by 21
Erdeve, Ş. S., Çetinkaya, S. Ç., Abalı, Z. Y., Poyrazoğlu, Ş., Baş, F., Berberoğlu, M., Şıklar, Z., Korkmaz, Ö., Buluş, D., Akbaş, E. D., et al. (2017) · Journal of Pediatric Endocrinology and Metabolism · doi:10.1515/jpem-2017-0088 · Cited by 21
Cordeiro, G. V., Silva, I. N., Goulart, E. M. A., das Chagas, A. J., & Kater, C. E. (2013) · Arquivos Brasileiros de Endocrinologia & Metabologia · doi:10.1590/s0004-27302013000200005 · Cited by 21
Yang, M., & White, P. C. (2025) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgae535 · Cited by 20
“Adult height and mean hydrocortisone doses are also influenced by genotype ( 106).”
Coeli‐Lacchini, F. B., Turatti, W., Elias, P. C. L., Elias, L. L. K., Martinelli, C. E., Moreira, A. C., Antonini, S. R. R., & de Castro, M. (2013) · Gene · doi:10.1016/j.gene.2013.03.082 · Cited by 18
Moreira, R. P. P., Jorge, A. A. L., Gomes, L. G., Kaupert, L. C., Filho, J. M., Mendonca, B. B., & Bachega, T. A. S. S. (2011) · Clinics · doi:10.1590/s1807-59322011000800009 · Cited by 17
Bizzarri, C., Improda, N., Maggioli, C., Capalbo, D., Roma, S., Porzio, O., Salerno, M., & Cappa, M. (2017) · Endocrine Practice · doi:10.4158/ep171751.or · Cited by 17
Engberg, H., Nordenström, A., & Hirschberg, A. (2025) · Journal of Clinical Endocrinology and Metabolism · doi:10.1210/clinem/dgae696 · Cited by 8
Troger, T., Sommer, G., Lang‐Muritano, M., Konrad, D., Kuhlmann, B., Zumsteg, U., & Flück, C. E. (2021) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgab701 · Cited by 16
GALLAGHER, M. P., Levine, L. S., & Oberfield, S. E. (2005) · Growth Hormone & IGF Research · doi:10.1016/j.ghir.2005.06.006 · Cited by 16
Merke, D. P., Mallappa, A., Parker, M., Sukin, C., Kulkarni, S. E., Keil, M. F., Ryzin, C. V., Hill, S. C., Reynolds, J. C., Cutler, G. B., et al. (2024) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgae824 · Cited by 13
21-Hydroxylase Genotyping in Australasian Patients with Congenital Adrenal Hyperplasia
Jeske, Y. W. A., McGown, I. N., Harris, M. A., Bowling, F. G., Choong, C. S., Cowley, D. M., & Cotterill, A. M. (2009) · Journal of Pediatric Endocrinology and Metabolism · doi:10.1515/jpem.2009.22.2.127 · Cited by 13
Prenatal and Early Postnatal Treatment of Congenital Adrenal Hyperplasia
Ghizzoni, L., Cesari, S., Cremonini, G., & Melandri, L. (2007) · Endocrine development · doi:10.1159/000111058 · Cited by 13
Gidlöf, S. B., Hogling, D. E., Lönnberg, H., Ritzen, M. E., Lajić, S., & Nordenström, A. (2023) · Hormone Research in Paediatrics · doi:10.1159/000535403 · Cited by 12
Pasqualini, T., Alonso, G., Tomasini, R., Galich, A. M., Buzzalino, N. D., Fernández, C. S., Minutolo, C., Alba, L. G., & Daín, L. (2007) · PubMed · Cited by 12
Long-term Growth in Congenital Adrenal Hyperplasia
Maheshwari, A., Khadilkar, V. V., Gangodkar, P. V., & Khadilkar, A. V. (2018) · The Indian Journal of Pediatrics · doi:10.1007/s12098-018-2753-6 · Cited by 11
de Lemos‐Marini, S. H. V., Guerra‐Júnior, G., Morcillo, A. M., Baptista, M. T. M., Silva, L. O., & Maciel‐Guerra, A. T. (2005) · Arquivos Brasileiros de Endocrinologia & Metabologia · doi:10.1590/s0004-27302005000600008 · Cited by 10
Bancos, I., Kim, H., Cheng, H. K.-H., Rodríguez-Lee, M., Coope, H., Cicero, S., Goldsmith, H., Lin, V. H., & Jeha, G. S. (2025) · Expert Review of Endocrinology & Metabolism · doi:10.1080/17446651.2025.2450423 · Cited by 9
Impact of Newborn Screening on Adult Height in Patients With Congenital Adrenal Hyperplasia (CAH)
Hoyer‐Kuhn, H., Eckert, A. J., Binder, G., Bonfig, W., Dübbers, A., Riedl, S., Woelfle, J., Dörr, H. G., & Holl, R. W. (2023) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgad307 · Cited by 9
Short-Term Growth in Children with Congenital Adrenal Hyperplasia
Liivak, K., Foster, P., Thalange, N. K. S., & Tillmann, V. (2009) · Hormone Research in Paediatrics · doi:10.1159/000197870 · Cited by 9
Blocs enzymatiques précoces de la surrénale
Samara‐Boustani, D., Bachelot, A., Pinto, G., Thibaud, E., Polak, M., & Touraine, P. A. (2008) · EMC - Endocrinologie - Nutrition · doi:10.1016/s1155-1941(08)40173-7 · Cited by 6
Sugiyama, Y., Mizuno, H., Hayashi, Y., Imamine, H., Ito, T., Kato, I., Yamamoto-Tomita, M., Aoyama, M., Asai, K., & Togari, H. (2008) · The Tohoku Journal of Experimental Medicine · doi:10.1620/tjem.215.341 · Cited by 5
Völkl, T. M. K., Rauh, M., Schöfl, C., & Dörr, H. G. (2011) · Growth Hormone & IGF Research · doi:10.1016/j.ghir.2011.05.001 · Cited by 5
Hyperplasie congénitale des surrénales: les formes précoces
Samara‐Boustani, D., Bachelot, A., Pinto, G., Thibaud, E., Touraine, P. A., & Polak, M. (2009) · EMC - Pédiatrie - Maladies infectieuses · doi:10.1016/s1637-5017(09)72438-x · Cited by 4
Medicalizing gender: from intersex to DSD, from the laboratory to patient groups
Crocetti, D. (2011) · AMS Dottorato Institutional Doctoral Theses Repository (University of Bologna) · doi:10.6092/unibo/amsdottorato/3282 · Cited by 4
Nguyen, T. T. H., Le, K., Tran, T. A. T., Nguyen, K. N., Can, T. B. N., Bui, P., Tran, D., & Vu, C. D. (2025) · Diagnostics · doi:10.3390/diagnostics15121534 · Cited by 3
Hassan, M. M., Ibrahim, A., Abdel-Salam, A., & Huthail, H. (2013) · Egyptian Pediatric Association Gazette · doi:10.1016/j.epag.2013.10.001 · Cited by 3
Ramos, C. C. A., Bento, L. R., Gonçalves, E. M., de Mello, M. P., Baptista, M. T. M., de Lemos‐Marini, S. H. V., & Guerra‐Júnior, G. (2007) · Revista Paulista de Pediatria · doi:10.1590/s0103-05822007000400004 · Cited by 3
Hypertrichose diffuse révélant une hyperplasie congénitale des surrénales de forme non classique
Berthin, C., Sibilia, P., Martins-Héricher, J., Donzeau, A., & Martin, L. (2018) · Annales de Dermatologie et de Vénéréologie · doi:10.1016/j.annder.2018.02.003 · Cited by 3
Final Heights in Patients with Congenital Adrenal Hyperplasia: A Retrospective Cohort Study
Rafiei, E., Rouhani, F., Bayat, E., Moeini, Z., & Dehnavi, N. (2025) · Journal of preventive medicine and hygiene · doi:10.15167/2421-4248/jpmh2025.66.3.3455 · Cited by 2
Current and future perspectives on clinical management of classic 21-hydroxylase deficiency
Yogi, A., & Kashimada, K. (2023) · Endocrine Journal · doi:10.1507/endocrj.ej23-0075 · Cited by 2
Disorders of sex development en stoornissen in de synthese van bijniersteroïden
Otten, B. J., der Grinten, H. L. C., & van Kuyk, E. M. (2008) · Tijdschrift voor kindergeneeskunde · doi:10.1007/bf03078192 · Cited by 3
Congenital Adrenal Hyperplasia and Growth Outcomes
Sharma, R. (2019) · The Indian Journal of Pediatrics · doi:10.1007/s12098-018-2841-7 · Cited by 2
Anthropometry in Congenital Adrenal Hyperplasia
Falhammar, H., Nordenström, A., & Thorén, M. C. (2012) · Springer eBooks · doi:10.1007/978-1-4419-1788-1_146 · Cited by 1
Treatment and Outcome of Congenital Adrenal Hyperplasia: 21-Hydroxylase Deficiency
Lee, P. A., Fuqua, J. S., & Nebesio, T. D. (2010) · International Journal of Pediatric Endocrinology · doi:10.1155/2010/276843 · Cited by 1
Inherited Metabolic Disorders: A Current Status
Shahid, M., Rasool, A., & Anjum, F. (2020) · Emerging contaminants and associated treatment technologies · doi:10.1007/978-3-030-45923-9_4 · Cited by 1
Troger, T., Sommer, G., Lang‐Muritano, M., Konrad, D., Kuhlmann, B. V., Zumsteg, U., & Fluck, C. E. (2022) · Yearbook of pediatric endocrinology · doi:10.1530/ey.19.8.6 · Cited by 1
Letoutchi, L. (2011) · Universitätsbibliothek der FU Berlin Hochschulschriftenstelle u. Dokumentenserver · doi:10.17169/refubium-6490
Hiperplasia suprarrenal congénita: formas precoces
Samara‐Boustani, D., Bachelot, A., Pinto, G., Thibaud, E., Touraine, P. A., & Polak, M. (2010) · EMC - Pediatría · doi:10.1016/s1245-1789(10)70185-2
Growth Hormone Therapy to Improve Adult Height in Patients with Congenital Adrenal Hyperplasia
Lin‐Su, K., Lekarev, O., & New, M. I. (2013) · Elsevier eBooks · doi:10.1016/b978-0-12-416006-4.00005-3
Pasqualini, T., Alonso, G., Fernández, C., Buzzalino, N., & Dain, L. (2013) · Archivos Argentinos de Pediatria · doi:10.5546/aap.2013.e35
Avaliação do crescimento e estatura final de pacientes com hiperplasia congenita de supra-renal
Kohara, S. K. (2007) · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas)
Congenital Adrenal Hyperplasia: Diagnosis, Management, and Long Term Outcomes
Ammini, A. C. (2014) · The Endocrine Society eBooks · doi:10.1210/mtp3.9781936704835.ch6
Nermoen, I. (2013) · NVA (Nasjonalt vitenarkiv)
Congenital adrenal hyperplasia
Daily, J. G., & Vigersky, R. (2013) · Elsevier eBooks · doi:10.1016/b978-1-4557-4975-1.00040-1
Debates and Controversies in Genetic Steroid Disorders
Speiser, P. (2013) · Elsevier eBooks · doi:10.1016/b978-0-12-416006-4.00030-2
Swendiman, R. A., Coons, B. E., Alter, C. A., Bamba, V., Nance, M. L., & Vogiatzi, M. G. (2019) · Journal of the Endocrine Society · doi:10.1210/jendso/bvz004
Chapter 31 – Congenital Adrenal Hyperplasia
Baquero, J. A., & Vigersky, R. (2009) · Elsevier eBooks · doi:10.1016/b978-0-323-05885-8.00031-3
Central Precocious Puberty as a Sign of Congenital Adrenal Hyperplasia: Case Presentations
Markosyan, R. L., & Navasardyan, L. V. (2020) · International Journal of Child Health and Nutrition · doi:10.6000/1929-4247.2020.09.04.5
Coeli‐Lacchini, F. B., Turatti, W., Elias, P. C. L., Elias, L. L. K., Martinelli, C. E., Moreira, A. C., Antonini, S. R. R., & de Castro, M. (2013) · Gene · doi:10.1016/j.gene.2013.09.109
(2006) · Current Opinion in Endocrinology & Diabetes · doi:10.1097/01.med.0000202323.44809.4f
(2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.89.11.9996
21-Hydroxylase Deficiency: Clinical and Biochemical Aspects
Nordenström, A., & Lajić, S. (2019) · Encyclopedia of Endocrine Diseases · doi:10.1016/b978-0-12-801238-3.65208-x
Congenital adrenal hyperplasia in children
Riepe, F. G. (2011) · doi:10.1093/med/9780199235292.003.7122
Metadata
- Authors
- Balsamo, A., Cicognani, A., Baldazzi, L., Barbaro, M., Baronio, F., Gennari, M., Bal, M., Cassio, A., Kontaxaki, K., & Cacciari, E.
- Affiliations
- IRCCS Azienda Ospedliero-Universitaria di Bologna Policlinico di Sant'Orsola (IT)
- Corresponding author
- Cacciari, Emanuele
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2003-12-01
- Volume
- 88
- Issue
- 12
- Pages
- 5680-5688
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- OpenAlex
- W2074732687
- Cited by
- 102
- References
- 37
- Citations by year
- 2026: 2 · 2025: 3 · 2024: 3 · 2023: 4 · 2022: 4 · 2021: 2 · 2020: 6 · 2019: 3 · 2018: 5 · 2017: 2 · 2016: 2 · 2015: 2 · 2014: 3 · 2013: 10 · 2012: 2
- FWCI
- 1.15
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
- PubMed (publishedVersion)
- Archivio istituzionale della ricerca (Alma Mater Studiorum Università di Bologna) (submittedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Sexual Differentiation and Disorders
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Clinical Biochemistry › Metabolism and Genetic Disorders
- Keywords
- 21-hydroxylase deficiency, congenital adrenal hyperplasia, adult height, pubertal development, mineralocorticoid therapy, early diagnosis, newborn screening, residual enzyme activity, compound heterozygosity, genotype-phenotype correlation, growth outcomes
- MeSH terms
- Adrenal Hyperplasia, Congenital, Aging, Body Height, Child, Child, Preschool, Female, Fertility, Genotype, Humans, Infant, Infant, Newborn, Male, Mineralocorticoids, Prognosis, Puberty, Retrospective Studies, Steroid 21-Hydroxylase
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.